Bristol-Myers Squibb: Notes placement for $2.0 billion
12:24 EDT 27 Jul 2012 | Current Partnering
Bristol-Myers Squibb Company has agreed to sell $2.0 billion of senior unsecured notes: $750 million in aggregate principal amount of 0.875% notes due 2017, $750 million in aggregate principal amount of 2.000% notes due 2022 and $500 million in aggregate principal amount of 3.250% notes due 2042 in an underwritten public offering. Citigroup Global Markets [...]The post Bristol-Myers Squibb: Notes placement for $2.0 billion appeared first on Current Partnering
Original Article: Bristol-Myers Squibb: Notes placement for $2.0 billion
More From BioPortfolio on "Bristol-Myers Squibb: Notes placement for $2.0 billion"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
